arrow
I

Ilaria Mastrorosa

national institute for infection disease lazzaro spallanzani irccs
H指数:14
被引数:805

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HIV INFECTION AMONG ADOLESCENTS AND YOUNG ADULTS IN ITALY: EPIDEMIOLOGY, VIRO-IMMUNOLOGICAL AND TREATMENT OUTCOMES

意大利青少年和年轻成人中的HIV感染:流行病学、病毒-免疫学及治疗效果

2025-11-150
OAAI
Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects

长期新冠患者感染SARS-CoV-2后三个月和一年观察到的炎症微环境及特异T细胞应答

2025-10-270
OAAI
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments

SARS-CoV-2感染后,活动性血液疾病患者在接受联合抗病毒治疗情况下重新开始抗癌治疗的时间

2025-10-010
OAAI
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study)

从依非韦伦/恩曲他滨/替诺福韦二吡呋酯转换为比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺,用于病毒学抑制的HIV感染者:一项非随机临床试验(EBONY研究)的结果

2025-06-180
OAAI
Comparative Effectiveness of Antiviral Agents and Monoclonal Antibodies for Early SARS-CoV-2 Therapy in Immunocompromised Patients: A Multicenter Retrospective Cohort Study (March 2021-March 2022)

免疫缺陷患者早期SARS-CoV-2治疗中抗病毒药物与单克隆抗体的比较疗效:一项多中心回顾性队列研究(2021年3月-2022年3月)

2025-05-060
OA
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves
2024-11-010
OAAI
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition
AIDS
IF3.1
2024-10-240
PRE
Impact of Anti-SARS-CoV-2 Vaccination on Disease Severity and Clinical Outcomes of Individuals Hospitalized for COVID-19 Throughout Successive Pandemic Waves: Data from an Italian Reference Hospital

在连续的大流行浪潮中,Anti-SARS-CoV-2疫苗接种对新型冠状病毒肺炎住院患者的疾病严重程度和临床结局的影响: 来自意大利参考医院的数据

2024-09-062
OAAI
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis

风险意识是意大利地区Mpox疫苗接种运动中早期疫苗接种的关键决定因素: 横断面分析

2023-11-273
OAAI
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes

在意大利参考医院因新型冠状病毒肺炎住院的患者中,在Delta和Omicron共循环期间关注的SARS-CoV-2变异的演变: 对临床结果的影响

2023-05-296
OAAI
What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis

post-COVID-19综合征对健康相关生活质量及相关因素的影响: 横断面分析

2023-03-2212
OAAI
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
2023-03-011
OAAI
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis
2022-12-018
OAAI
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents

单克隆抗体和直接抗病毒药物治疗后,SARS-CoV-2 BA.1和BA.2 Omicron亚系感染的病毒载量降低

2022-10-0717
OAAI